25 -11 (49) 2022 — Urakov Sh.T., Makhmanazarov O.M. — THE ROLE OF BACTERIAL TRANSLOCATION IN THE DEVELOPMENT OF SYSTEMIC INFLAMMATION IN PATIENTS WITH CIRRHOSIS OF THE LIVER

THE ROLE OF BACTERIAL TRANSLOCATION IN THE DEVELOPMENT OF SYSTEMIC INFLAMMATION IN PATIENTS WITH CIRRHOSIS OF THE LIVER

Urakov Sh.T., Bukhara State Medical Institute

Makhmanazarov O.M. Bukhara State Medical Institute

Resume

The study included 52 patients with cirrhosis of the liver and 16 clinically healthy individuals of the control group. In all patients, the excess bacterial growth syndrome was determined using a hydrogen breath test with lactulose, the level of C-reactive protein in blood plasma and duplex scanning of unpaired vessels of the abdominal cavity with determination of their diameter, linear and volumetric blood flow rates, and for arteries – also the resistance index. The expansion of the arteries of the stomach and intestines and the growth of blood flow through them with cirrhosis of the liver are observed only in the presence of the syndrome of excessive bacterial growth. In patients with cirrhosis of the liver without the syndrome of excessive bacterial growth, the indicators of gastrointestinal blood flow practically do not differ from those of clinically healthy individuals. The development of bacterial overgrowth syndrome in cirrhosis of the liver is associated with more frequent development of ascites (OR=3.15) and varicose veins of the esophagus of the 3rd degree (OR=4.99). The blood flow through the splenic artery and vein, as well as the severity of splenomegaly and hypersplenism in cirrhosis of the liver, practically do not depend on the presence of excessive bacterial growth syndrome.

Key words: liver cirrhosis, excessive bacterial growth, systemic inflammatory reaction, bacterial translocation, portal blood flow, mesenteric blood flow.

First page

142

Last page

146

For citation:Urakov Sh.T., Makhmanazarov O.M. – THE ROLE OF BACTERIAL TRANSLOCATION IN THE DEVELOPMENT OF SYSTEMIC INFLAMMATION IN PATIENTS WITH CIRRHOSIS OF THE LIVER //New Day in Medicine 11(49)2022 142-146 https://clck.ru/32gH7x

LIST OF REFERENCES:

1. Ардатская М.Д., Бельмер С.В., Добрица В.П. и др. Дисбиоз (дисбактериоз) кишечника: современное состояние пробле­мы, комплексная диагностика и лечебная коррекция. // Экспе­риментальная и клиническая гастроэнтерология. 2015; 5:13-50.
2. Жаркова М.С., Маевская М.В., Ивашкин В.Т. Современный взгляд на бактериальные осложнения при циррозе печени. // Рос журнал гастроэнтерологии, гепатологии,  колопроктологии. 2010;20(6): 61-69
3. Жаркова М.С., Маевская М. В., Ивашкин В.Т. Влияние синдрома избыточного бактериального роста и бактериальной транслокации на течение заболевания у больных циррозом печени. // Рос журн гастроэнтерол гепато- колопроктол 2012;22(5):56-63
4. Шибитов В.А. Энтеральный дистресс синдром при острой кишечной непроходимости различного происхождения. / Автореф., дис. … докт. Мед. наук. Саранск 2018. -С.18-35.
5. Яковенко Э.П., Агафонова Н.А., Яковенко А. В. и соавт. Син­дром избыточного бактериального роста в кишечнике – кли­ническое значение и вопросы терапии. // Consilium medicum. 2006. Экстравыпуск. 3-8.
6. Bernardi M. et al. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. // J Hepatol 2015; 63: 1272-84.  
7. De Franchis R. Expanding consensus in portal hypertension:       Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. // J Hepatol 2015;63(3):743-52
8. Giannelli V.,  Di Gregorio V., Iebba V. et al. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. // World J. Gastroenterol 2014; 20(45):16795-810.
9. Zhang Y., Feng Y., Cao B., Tian Q. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. // Arch Med Sci 2016;12(3):592-6.
10. Yao J., Chang L., Yuan L., Duan Z. Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis. // Asia Pac J Clin Nutr 2016;25(2):283-91.